A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 23
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NHB
Long Form : net health benefit
No. Year Title Co-occurring Abbreviation
2017 Challenges in the Clinical Application of the American Society of Clinical Oncology Value Framework: A Medicare Cost-Benefit Analysis in Chronic Lymphocytic Leukemia. NCCN
2017 Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework. ASCO, ESMO, ESMO-MCBS, GEP-NET, NHB-ASCO-F
2017 Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men. MR, QALYs, US, WTP
2017 Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center. ASCO, CEA, ICERs, MOC, UCSF
2017 Liver Resection for Breast Cancer Liver Metastases: A Cost-utility Analysis. QALMs
2017 The Evolution of Metastatic Colorectal Cancer Clinical Trials: Application of the ASCO Framework for Assessing Value. mCRC
2017 Value Frameworks for the Patient-Provider Interaction: A Comparison of the ASCO Value Framework Versus NCCN Evidence Blocks in Determining Value in Oncology. ASCO, AVF, NCCN, NEB, NSCLC
2016 Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer? AURELIA, BEV, ICER, LYS, PROC
2015 Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis. CEA, CT, DLM, HAI, HR, ICER, MRI, QALMs, QALY, SCT
10  2015 Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis. HR, ICC, ICER, QALMs, QALY, SCT
11  2015 Net health benefit of hepatic resection versus intraarterial therapies for neuroendocrine liver metastases: A Markov decision model. HR, IAT, ICER, NELM, QALMs, QALY
12  2015 The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. HCC, LR, LT, QALYs, RFA
13  2015 Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor. AFP, CTP, HCC, LT
14  2013 Effects of changing mosquito host searching behaviour on the cost effectiveness of a mass distribution of long-lasting, insecticidal nets: a modelling study. DALYs, LLINs
15  2013 Effects of pyrethroid resistance on the cost effectiveness of a mass distribution of long-lasting insecticidal nets: a modelling study. DALYs, LLINs
16  2013 [Adalimumab versus etanercept in the treatment of active rheumatoid arthritis: cost-effectiveness analysis]. ADA, DAS28a, ETN, RA
17  2010 Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. HCC, HR, LT, QALDs, WTP
18  2008 Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease. ABI, CAD, ICER, PAD, QALYs
19  2008 Cost-effectiveness of palliation of unresectable esophageal cancer. CE, EC, ICER, SES, WTP
20  2006 Nonparametric statistical methods for cost-effectiveness analyses. ICER
21  2002 Statistical determination of cost-effectiveness frontier based on net health benefits. CMCB
22  2001 Statistical cost-effectiveness analysis of two treatments based on net health benefits. CEA, WTP
23  2000 Fieller's method and net health benefits. ICER, INHB